Download Citation
Article Source:
A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1
Yabuki C,
Komatsu H,
Tsujihata Y,
Maeda R,
Ito R,
et al.
(2013)
A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1.
PLOS ONE 8(10): e76280.
https://doi.org/10.1371/journal.pone.0076280